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Abstract
DDIT3, also known as GADD153 or CHOP, encodes a basic leucine zipper transcription factor of the dimer forming C/EBP
family. DDIT3 is known as a key regulator of cellular stress response, but its target genes and functions are not well
characterized. Here, we applied a genome wide microarray based expression analysis to identify DDIT3 target genes and
functions. By analyzing cells carrying tamoxifen inducible DDIT3 expression constructs we show distinct gene expression
profiles for cells with cytoplasmic and nuclear localized DDIT3. Of 175 target genes identified only 3 were regulated by
DDIT3 in both cellular localizations. More than two thirds of the genes were downregulated, supporting a role for DDIT3 as a
dominant negative factor that could act by either cytoplasmic or nuclear sequestration of dimer forming transcription factor
partners. Functional annotation of target genes showed cell migration, proliferation and apoptosis/survival as the most
affected categories. Cytoplasmic DDIT3 affected more migration associated genes, while nuclear DDIT3 regulated more cell
cycle controlling genes. Cell culture experiments confirmed that cytoplasmic DDIT3 inhibited migration, while nuclear
DDIT3 caused a G1 cell cycle arrest. Promoters of target genes showed no common sequence motifs, reflecting that DDIT3
forms heterodimers with several alternative transcription factors that bind to different motifs. We conclude that expression
of cytoplasmic DDIT3 regulated 94 genes. Nuclear translocation of DDIT3 regulated 81 additional genes linked to functions
already affected by cytoplasmic DDIT3. Characterization of DDIT3 regulated functions helps understanding its role in stress
response and involvement in cancer and degenerative disorders.
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Introduction
DDIT3 (DNA damage induced transcript 3) also known as
GADD153 (G1 arrest and DNA damage 153) or CHOP (C/EBP
homologous protein), encodes a key regulator of stress response.
DNA damage, ER stress, hypoxia, and starvation induce DDIT3
transcription, mRNA stability, and translation, resulting in DDIT3
protein accumulation [1,2,3,4,5,6,7,8,9]. The biological activity of
the DDIT3 protein is further regulated by phosphorylation [10].
Forced expression of DDIT3 triggers cell cycle arrest and in some
cell types apoptosis, indicating a central role in these stress effects
[11,12]. DDIT3 has been implicated in stress responses leading to
death of pancreatic insulin producing b-cells and in neurodegen-
erative disorders [8,13,14] . DDIT3 is also involved in differen-
tiation of specialized tissues and cells [15,16,17,18,19] and as an
oncogene in sarcomas [20,21].
The DDIT3 encoded protein is a basic leucine zipper (BZIP)
transcription factor of the dimer forming C/EBP family [18,22].
Unlike other C/EBP transcription factors, DDIT3 cannot form
homodimers. Instead, DDIT3 acts as a dominant negative factor
that blocks the activities of other C/EBP proteins by forming
heterodimers. However, DDIT3 can also bind DNA as a
heterodimer and induce transcription of down-stream target genes
[23]. An intrinsically disordered domain in DDIT3 was reported
to bind proteins other than leucine zippers [24]. DDIT3 was
initially regarded as a nuclear protein but has also been reported
to be expressed as a cytoplasmic protein in erythroid leukemia
and kidney proximal tubular epithelial cells [25,26]. In mouse
fibroblasts, nuclear localization of DDIT3 was shown to depend
on dimerization with the short isoform of CEBPB (also known
as LIP) [27,28]. The cytoplasmic localization indicate func-
tions others than direct transcriptional regulation, and raise the
question whether nuclear and cytoplasmic DDIT3 trigger distinct
responses.
Here, we show a predominantly cytoplasmic localization of
stress induced DDIT3 in human fibroblasts and sarcoma cells.
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The effects of cytoplasmic and nuclear DDIT3 protein were
studied in stably transfected cell clones that express high levels of
DDIT3 fused to the ligand binding parts of the mouse estrogen
receptor (mor). The mor part retains the recombinant protein in
the cytoplasm and addition of tamoxifen induces a rapid
translocation of the recombinant DDIT3 from cytoplasm to the
nuclei of stably transfected cells. Employing microarray, reverse
transcription quantitative real-time PCR, and western blot
methods, we identified DDIT3 regulated genes and functions.
Our analysis shows that cytoplasmic and nuclear DDIT3 induced
distinct gene expression patterns and functions.
Materials and Methods
Expression vectors
The full length coding region of DDIT3 was cloned into the
pEGFP-N1 vector (Clontech Laboratories, Inc.) in frame with the
EGFP [29]. MorEGFP vectors were constructed by an in-frame
ligation of the morLBD construct upstream of the gene encoding
EGFP. All constructs were confirmed by sequencing. The mouse
estrogen receptor ligand binding domain (morLBD) construct was
made by mutating the wild-type mouse oestrogen receptor (a kind
gift from Dr. M. Parker). The ligand binding domain (DNA
encoding amino acids 290–599) of the receptor was cloned using
the primer set: MORLBD BamHI-U (59-TATGGATCCAG-
GAGACATGAGGGCTGCCAACCTTTG-39) and MORLBD
BamHI-L (59-TATGGATCCATCGTGTTGGGGAAGCCCT-
CT-39). The G525R point mutation was introduced by PCR
mutagenesis and amplification of circular DNA in vitro [30] using
the primer set: MORLBD mut-U (59-GGCACATGAGTAA-
CAAACGCATGG-39) and MORLBD mut-L (59ATGTTGTA-
GAGATGCTCCATGCGTTTGTT-39). The morLBD G525R
mutant is unable to bind estrogen, but retains affinity for the
synthetic ligand 4-hydroxy-tamoxifen (Sigma-Aldrich). For nuclear
translocation of mutant morLBD fused DDIT3-GFP in transfected
cells, 4-hydroxy-tamoxifen was added to the medium at a final
concentration of 100 nM [31].
Cell cultures and RNA extraction
The GOT3 liposarcoma cell line, human F470 fibroblasts and
human parental fibrosarcoma cell line HT1080 and transfected
clones were cultured at 37uC and 5% CO2 in RPMI 1640 medium
supplemented with 2 mM L-glutamine, 50 U/ml penicillin, 50 g/
ml streptomycin and 8% FCS (all Invitrogen). G418 (200 g/ml,
Invitrogen) was constantly added to the transfected clones to
ensure stable expression of EGFP constructs in the cell population.
Low fetal bovine serum concentrations (1%) were used for stress
induction experiments with fibroblasts and GOT3 cells to reduce
fetal bovine serum induced background expression of DDIT3.
Tunicamycin and etoposide (both Sigma-Aldrich) were used at
final concentrations of 2 mg/ml and 30 mM, respectively. For
experiments with forskolin treatment, cells were seeded in Petri
dishes (35 mm) at a density of 180 000 cells per plate. Forskolin
was added in a concentration of 1.8*1025 M. The experiments
were performed in 3 independent biological replicates.
RNA was extracted using RNAeasy extraction kit (Qiagen) from
cells before, 2 and 8 hours after addition of 4-hydroxy-tamoxifen
and stored at 2140uC until analysis.
Microarray experiments and analysis
RNA samples and a common human universal reference RNA
(Stratagene) were used as templates for cDNA synthesis with Cy3 and
Cy5 labeled nucleotides, according to the instructions for the Pronto
Plus 6 labeling kit (Corning). Equal quantities of labeled cDNA and
reference cDNA were hybridized to Agilent G4112F microarrays and
the arrays were scanned using an Agilent G2565CA microarray
scanner (Agilent Technologies). Feature extraction was performed
with Agilent’s Feature Extraction 10.4 Image Analysis Software.
Data analysis was performed with the open source statistical
software R using the LIMMA package available within Biocon-
ductor [32]. A loess smoother was applied to each array to remove
intensity dependent trends and the arrays were quantile normal-
ized for comparability. All spots not corresponding to human
genes were removed before further analysis. The expression levels
of duplicated probes were averaged. The biological replicates were
made with different clones, the replicate similarities were therefore
assessed using Pearson correlations. The replicates exhibited
consistent high correlations (all.0.85) and no systematic devia-
tions were found within or between clones (data not shown). For
each probe on the array, the normalized log2-fold change (M-
value) was calculated and retained for downstream analysis. To
assess the changes in gene expression induced by cytoplasmic
DDIT3, the M-values were compared for the zero time point in
the DDIT3morEGFP cell line with the zero time point in the cell
line with the morEGFP construct alone. Similarly, the differen-
tially expressed genes induced by nuclear DDIT3 for the 2 and
8 hours time points were compared to the zero time point of the
DDIT3morEGFP cell line (creating 2 so-called contrasts). The
same procedure was employed in the control cell line. In order to
remove any effects induced by the morEGFP construct alone, a
1.5 fold-change or higher in either contrast were discarded before
further analysis. EGR1, with a regulation slightly larger than 1.5
fold in the morEGFP cell line, was also included because of a very
large fold-change at the 8 hours time point. Genes regulated by
the morEGFP construct alone were not removed from the analysis
of cytoplasmic DDIT3 induced genes. Raw and normalized
microarray data has been deposited according to MIAME
standards in the MIAME compliant ArrayExpress database under
accession number E-MEXP-2709.
Functional annotation and network analysis
Probes on the microarrays were ranked according to their M-
values (log2 fold-change). The response induced by cytoplasmic
DDIT3 was more pronounced than for nuclear DDIT3.
Therefore, a 3-fold and a 2-fold cutoff for regulated genes were
used, respectively. The functional analysis of the regulated genes
was generated through the use of Ingenuity Pathways Analysis
(IngenuityH Systems). Genes that met the above described
expression criteria and were associated with biological functions
and/or diseases in the Ingenuity Pathways Knowledge Base were
considered for the analysis. Enriched functional categories and
subgroups within each category among the regulated genes were
identified for all gene sets, and the 4 most significant categories
representing fundamental cellular functions in each set were
chosen for further study. The ‘‘cancer’’ category was omitted,
since we do not consider cancer as a cellular functional category.
Fischer’s exact test [33] was used to calculate a p-value
determining the probability that each biological function and/or
disease assigned to that data set was due to chance alone. To
generate functional networks, the differentially expressed genes
were overlaid onto a global molecular network developed from
information contained in the Ingenuity Pathways Knowledge
Base. Networks of these focus genes were then algorithmically
generated based on their connectivity.
Cell migration assay
Wild type and stably transfected HT1080 cells were seeded to
petri dishes (35 mm) in a 1:1 ratio with 100 000 cells per well. At
Effects of Nuclear and Cytoplasmic DDIT3
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e33208
80% confluence, a scratch wound was made in the cell monolayer.
In experiments with tamoxifen treatment, the drug was added at
the time of scratch wound. After 24 hr of incubation the cultures
were fixed in 4% formaldehyde (Sigma-Aldrich) and stained with
ethidium bromide (Thermo Scientific) at a final concentration of
20 mg/ml. Wounded areas were photographed on a fluorescence
microscope after 24 hours incubation and the number of ethidium
bromide stained cells and EGFP stained cells were counted. Cells
were also counted in several non-wounded control areas. The
experiment was repeated 6 times for each of the HT1080 cell lines
transfected with EGFP, DDIT3-EGFP and 10 times for cell with
DDIT3morEGFP or morEGFP. For detailed description of the
migration assay modeling, see Material and Methods S1. Briefly,
the ratios of migration rates for all EGFP stained cell types and
migration rate for wild type cells can be deduced by using Bayes
theorem. A Wilcoxon test was employed to test the differences in
migration rates between different EGFP stained cell lines.
Promoter analysis
Transcription factor binding sites (TFBS) were predicted using
the MATCH program [34] and a collection of 652 vertebrate
positions-scoring weight matrices (PWMs) from the TRANSFAC
database [35]. Promoter sequences were extracted from the
TRANSPro database, where 500 base pairs upstream and 100
base pairs downstream of the predicted transcription start site were
selected for each gene. Matches to a PWM were considered a hit if
either the core similarity score was 1.0 or the matrix similarity score
exceeded 0.95 (conservative choice). CRE sites present in the
promoters of the nuclear DDIT3 regulated genes at two hours were
predicted by counting hits for the following PWMs: V$CRE-
BATF_Q6, V$CREBP1CJUN_01, V$CREBP1_01, V$CREBP1_
Q2, V$CREB_01, V$CREB_02, V$CREB_Q2, V$CREB_Q2_01,
V$CREB_Q3, V$CREB_Q4, V$CREB_Q4_01, V$TAXCREB_01
and V$TAXCREB_02.
The enrichment of all TFBS among the regulated genes at
2 hours was tested in 2 different ways. A hypergeometric test was
used to compare the proportion of hits of TFBS among the
regulated genes and the non-regulated genes. This method is
standard procedure, but is highly dependent on the choice of cut-
off value for regulation, and may also be sensitive to the fact that
the number of regulated genes is relatively small. As a
complement, a permutation test was applied to all the genes
present on the arrays (i.e. not based explicitly on the regulation
cut-off). Detailed description of the permutation test are given in
Material and Methods S2. The permutation test works as a
complement to the hypergeometric test, and ideally low p-values
with both methods should indicate significant enrichment of
TFBS.
Reverse transcription quantitative real-time PCR
Reverse transcription for microarray validation was performed
on approximately 1 mg total RNA using SuperScript III (Invitro-
gen) according to the manufacturers’ instructions, using a mixture
of 5 mM oligo(dT) and 5 mM random hexamers (both Invitrogen)
as primers. Real-time PCR measurements were performed on a
LightCycler 480 (Roche) using the iQ SYBR Green Supermix
(Bio-Rad) with 400 nM of each PCR primer (TAG Copenhagen
A/S). Primer sequences are available in Table S1. Formation of
correctly sized PCR products was confirmed by agarose gel
electrophoresis for all assays and melting curve analysis for all
samples. Gene expression data was normalized against PPIA and
HPRT by geometric averaging [36]. The reference genes were
selected using the Human Endogenous Control Gene Panel
(TATAA Biocenter) and GenEx software (MultiD Analyses).
For the Forskolin experiment QuantiTect Reverse Transcrip-
tion Kit and QuantiTect SYBR Green Kit (both QIAGEN) were
used for reverse transcription and real-time PCR, respectively.
Data was normalized against GAPDH.
Fluorescence microscopy and western blot analysis
Fluorescence microscopy and western blot analysis was
preformed as previously described [37]. A Leica DMI 600B
microscope with a Leica DFC 360 FX camera was used for life
imaging. The recording was made during a 1 hour time span with
an image taken every 20 seconds (tamoxifen at a final concentra-
tion of 100 nM was added after 5 minutes). The software used for
recording was the Leica Application Suite AF. Antibodies used
were rabbit anti GADD153 (DDIT3), R20 (Santa Cruz Biotech-
nology), GAPDH, mouse monoclonal 9484 (Abcam), Histone H1,
mouse monoclonal AE-4 (Santa Cruz Biotechnology), EGFP,
mouse monoclonal JL-8 (Clontech), Lamin A, mouse monoclonal
133A2 (Abcam), ATF3, mouse monoclonal M04 (Nordic Biosite),
ATF4, mouse monoclonal 2B3 (Sigma-Aldrich), EGR1, mouse
monoclonal S-25 (Santa Cruz Biotechnology).
Flow cytometric analysis of cell cycle phase distribution
The distributions of G1, S, and G2 cells were analyzed at 24,
48, 78 hours after tamoxifen treatment using the FACScalibur
system (BD Biosciences). Cells were detached with trypsin/EDTA
solution and fixed in 70% ethanol. Isolated nuclei were stained
with propidium iodide staining solution containing: 0.1% Triton
X-100, 10 ug/mL propidium iodide, and 100 ug/mL DNase-free
RNase A in PBS (all Sigma-Aldrich). Standardized chicken and
Rainbow trout red blood cells were obtained from the FACS unit
at O¨rebro University, Sweden, and used as internal controls for
DNA amount. The ModFit LTTM software (Verity Software
House) was used for automatic analysis and peak detection to
identify ploidy patterns. Aneuploid G1 cells were excluded from
the diploid G2/M populations.
Results
Cytoplasmic accumulation of DDIT3 in stressed human
fibroblasts and GOT3 liposarcoma cells
Native DDIT3 was first reported to be expressed as a nuclear
transcription factor [18]. Here, we show that DDIT3 accumulated
largely as a cytoplasmic protein in human fibroblasts and GOT3
liposarcoma cells under ER stress induced by tunicamycin
interruption of protein glycosylation (Figure 1A). Similar results
were obtained in human cultured fibroblasts and GOT3
liposarcoma cells treated with the DNA damaging agent etoposide
(Figure S1). The GOT3 liposarcoma cell line carries a strongly
amplified DDIT3 gene [21] that results in a constitutive expression
of cytoplasmic DDIT3, which was further upregulated upon stress.
In contrast, transfection of GOT3 cells or normal fibroblasts with
a DDIT3-EGFP expression vector (not containing the mouse
estrogen receptor part) resulted in a nuclear localization of the
DDIT3-EGFP protein [38].
To investigate the specific effects of cytoplasmic and nuclear
DDIT3 we constructed HT1080 fibrosarcoma clones with stable
expression of the DDIT3morEGFP recombinant protein. Under
standard culture conditions, these cells showed a cytoplasmic
expression of the recombinant protein (Figure 1B and Figure S2).
Tamoxifen treatment of these cells caused a nuclear translocation
of the DDIT3morEGFP recombinant protein within 30 minutes
(Figure 1B and Movie S1).
Effects of Nuclear and Cytoplasmic DDIT3
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Genes, functions and networks regulated downstream of
cytoplasmic DDIT3morEGFP
Gene expression profiling of 41000 human transcripts was
performed by microarray analysis in two DDIT3morEGFP
transfected and two morEGFP transfected clones (For experiment
overview see Figure S3). Analysis of microarray data from cells
expressing cytoplasmic DDIT3morEGFP revealed 94 genes that
were regulated at least 3-fold compared to their expression in
morEGFP expressing cells (Table S2). Of the 94 genes, 33 genes
were upregulated and 61 downregulated. To confirm the accuracy
of the microarray experiments, 32 genes were selected and
validated using reverse transcription quantitative real-time PCR
analysis (Tables S2 and S3).
Ontology analysis of identified target genes showed that the
functional categories cellular movement, cell death, cellular development,
and cellular growth and proliferation were the most significantly
affected (Figure 2, Table S4). Some overlap between the genes
annotated to the different categories was observed (Figure S4A).
The 94 regulated genes were also overlayed onto the gene/protein
network defined in the Ingenuity Pathway Knowledge Base with
the aim to identify affected networks and network hubs (hubs are
genes/proteins connecting several paths of the network). None of
the DDIT3 regulated genes were found to be a major hub of the
most significant networks (Figure S5).
Cytoplasmic DDIT3 inhibits migration of HT1080 cells
Twenty of 94 regulated genes for cytoplasmic DDIT3 were
annotated to the functional category cellular movement (Table S2).
For example, DSTN, an actin-depolymerizing factor important for
remodeling of the cytoskeleton was down regulated and ATF3,
which has been shown to block migration, was upregulated.
Several extracellular matrix related genes such as FN1, fibronectin,
HAS2, hyaluronan synthetase and CSPG4, chondroitin sulfate
proteoglycan 4, were downregulated. The adhesion molecule
cadherin 11 was also downregulated. Taken together, the
cytoplasmic DDIT3 regulation of movement-associated genes
suggested a negative effect on cellular movement/migration.
To experimentally address the hypothesis that DDIT3 nega-
tively regulates migration, we used a modified scratch wound
migration assay. Migration was inhibited with 48% (P,0.01) for
DDIT3morEGFP expressing HT1080 cells compared to mor-
EGFP expressing cells. When tamoxifen was added to both these
cell lines, the corresponding migration inhibition was 42%
(P,0.01) (Material and Methods S1).
Genes, functions and networks regulated by nuclear
DDIT3morEGFP
To identify direct target genes and effects of nuclear DDIT3,
microarray analysis was performed 2 and 8 hours after tamoxifen
activation and cytoplasmic release of DDIT3 (for experiment
Figure 1. Subcellular localization of DDIT3. (A) Immunoblot analyses of nuclear (Nu) and cytoplasmic (Cy) extracts of human liposarcoma cell
line GOT3 and normal human fibroblasts F470 following 8 hours of tunicamycin (2 mg/ml,Tunica) treatment. Cytoplasmic accumulation of DDIT3 is
seen in both cell lines compared to untreated cells (Control). GAPDH and Lamin A are cytoplasmic and nuclear markers, respectively. (B) Confocal
microscopy (upper panel) of HT1080 cells containing DDIT3morEGFP before and 1 hour after addition of tamoxifen (100 nM). A translocation of the
EGFP tagged recombinant DDIT3 protein from the cytoplasm to the nucleus can be seen after the addition of tamoxifen (See also Movie S1).
Immunoblot analyses (lower panel) of nuclear and cytoplasmic extracts. GAPDH and H1A were used as cytoplasmic and nuclear markers, respectively.
doi:10.1371/journal.pone.0033208.g001
Figure 2. Functional gene categories regulated by cytoplasmic
and nuclear DDIT3. Enrichment of functional gene categories
regulated by cytoplasmic DDIT3 (white bars), and nuclear DDIT3 at 2
and 8 hours (striped bars and black bars, respectively) after tamoxifen
treatment of HT1080 cells containing DDIT3morEGFP and morEGFP. The
categories are ordered by the significance for cytoplasmic DDIT3
regulated genes. The y-axis shows log10 transformation of enrichment
p-values.
doi:10.1371/journal.pone.0033208.g002
Effects of Nuclear and Cytoplasmic DDIT3
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overview see Figure S3). Only short time periods were allowed for
accumulation and degradation of mRNAs regulated by nuclear
DDIT3 compared to cytoplasmic DDIT3 expressing cells.
Therefore, we applied a 2-fold and 3-fold cutoff for those mRNAs,
respectively. After 2 hours, 45 genes were regulated (Figure 3A
and Table S2). Eight hours after DDIT3 translocation, several
initially regulated genes were back to their initial expression levels,
but replaced by other response genes. In total 52 genes were
regulated 8 hours after DDIT3 translocation, but only 13 of these
genes were regulated after 2 hours (Figure 3A and Table S2). Most
of the regulated genes were repressed, supporting the hypothesis
that DDIT3 acts as a dominant negative factor [18].
Functional analysis among the 2 hours response genes for nuclear
DDIT3 showed that the top enriched categories were cell death,
cellular development, cellular growth and proliferation and cell cycle (Figure 2).
Examples of a functional subgroup within respective category were:
apoptosis (p = 161026), development of cells (p = 961024), growth of cells
(p = 361025) and interphase (p = 861026) (Table S4B).
Cell death, gene expression, cellular development, and cell cycle were the
most significant categories enriched among the 8 hours response
genes of nuclear DDIT3, however all subgroups within cellular
development contained only a small number of genes (Figure 2 and
Table S4). Genes of all categories overlapped, but not to the same
extent as for the categories in the 2 hours time point (Figure S4B-C).
Examples of functional subgroups of the cell death, gene expression, and
cell cycle categories were apoptosis (p = 161025), transcription
(p = 261025) and M phase of eukaryotic cells (p = 461024) (Table S4).
Network analysis based on the regulated genes from 2 and
8 hours after nuclear transition of DDIT3 showed that the
transcription factor gene EGR1 may work as a hub connecting
several paths in the network (Figure S5). EGR1 was the single most
upregulated gene and this regulation was confirmed at protein
level by western blot analysis (Figure S1),
Nuclear translocation of DDIT3morEGFP leads to a
transient G1 arrest
Functional analysis of our microarray results suggested that
DDIT3 regulated genes were involved in cell cycle control and
apoptosis. To test these functions we studied cell cycle progression
and cell survival. Nuclear translocation of DDIT3morEGFP in
HT1080 cells caused a transient growth arrest with accumulation
of cells in the G1-phase and depletion of cells in the S- and G2-
phases (Figure 4), whereas no growth effects were observed in the
morEGFP expressing cells (data not shown). No increased level of
apoptotic cells was observed in DDIT3morEGFP expressing cells
before or after tamoxifen treatment (data not shown).
Cytoplasmic and nuclear DDIT3 regulate different genes
but with overlapping functions
Ninety-one of 94 genes regulated by cytoplasmic DDIT3
remained at their initial expression levels after the nuclear
translocation of DDIT3 (Figure S6). Exceptions were ATF3 and
HSPA1A, which were upregulated, and TPO, which was
downregulated in cells with cytoplasmic DDIT3 (Figure 3B).
Nuclear translocation of DDIT3 partially or completely reduced
the cytoplasmic DDIT3 effect on the expression of these 3 genes.
ATF3 regulation was confirmed by immunoblot analysis (Figure
S1). In addition to the 94 genes and functions regulated by
cytoplasmic DDIT3, 81 more genes were regulated after nuclear
translocation (Figure 3A, Figure S6).Target genes of nuclear
DDIT3 belonged to functional categories that were already
significantly enriched by cytoplasmic DDIT3 (Figure 2).
Promoter analysis of DDIT3 regulated genes
Genes regulated by nuclear DDIT3 after 2 hours of tamoxifen
treatment were considered direct targets of DDIT3. Two different
scoring methods for enrichment of predicted transcription factor
binding sites (TFBS) using 652 position-scoring weight matrices
(PWMs) were applied. Ideally, hits to a PWM should be present in
most genes regulated, but not enriched in randomly selected
reference gene panels.
A few binding sites, for example V$AP2_Q6, V$SP1_Q2_01,
V$CNOT3_01 and V$SRF_01, showed moderately low p-values
for enrichment among the regulated genes with both scoring
methods (Table S5). In addition, several of the top scoring PWMs
had putative binding sites in the reference genes. Follow up
analyses including clustering and functional annotation failed to
identify a common pattern of binding site occurrence in the
promoters of the regulated genes.
DDIT3 forms dimers with other C/EBP leucine zipper factors
and acts as a dominant negative factor or binds as heterodimers to
specific sites [23]. However, neither the C/EBP sites, nor the
reported DDIT3 (CHOP) binding sites were enriched among the
regulated genes.
Twenty of the genes regulated by nuclear DDIT3 contained a
cAMP responsive element (CRE) site in their promoter region.
Despite difficulties in showing significant enrichment for these
Figure 3. Genes regulated by cytoplasmic and nuclear DDIT3.
(A) Genes regulated 2 and 8 hours after nuclear translocation of DDIT3
in DDIT3morGFP expressing HT1080 cells. (B) Genes regulated both by
cytoplasmic DDIT3 and nuclear DDIT3. White bars represent regulation
by cytoplasmic DDIT3. Grey and black bars represent the regulation of
nuclear DDIT3 compared to levels in cells with cytoplasmic DDIT3 at 2
and 8 hours after tamoxifen addition, respectively.
doi:10.1371/journal.pone.0033208.g003
Effects of Nuclear and Cytoplasmic DDIT3
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CRE sites, we decided to further investigate a possible interaction
with DDIT3, since several CRE binding proteins belong to the
basic leucine zipper family of transcription factors that may form
heterodimers with DDIT3 [39]. HT1080 cells expressing EGFP or
nuclear DDIT3-EGFP were treated with the cAMP inducing
agent forskolin and expression of responsive genes was analyzed by
reverse transcription quantitative real-time PCR. Six genes
(DUSP1, FOSL2, JUN, KLF13, NR4A3 and SNF1LK) reported to
be cAMP regulated were analyzed. Although the DDIT3 effects
on forskolin induction varied between the genes, there was no
general inhibition of the forskolin induced effect (Figure S7). This
indicates that there is no general dominant negative effect of
DDIT3 in cAMP regulated transcription factor complexes of these
6 genes.
Discussion
Mammalian cells respond to stress with specific gene expression
and protein activation programs, evolved to minimize damage or
induce apoptosis. DDIT3 is a key regulator in stress response and
DDIT3 accumulation is regulated both at transcriptional, mRNA
stability and translational levels [40]. Mice lacking DDIT3
develops normally but with impaired osteoblast function [41].
However, DDIT32/2 cells are resistant to ER stress mediated
apoptosis [12,42,43] and this is reflected in animal models of cell
stress associated degenerative diseases [8].
DDIT3 was initially described as a nuclear transcription factor,
but later reports suggest that DDIT3 can be expressed in the
cytoplasm [25,26]. Here we show that GOT3 sarcoma cells and
normal human fibroblasts accumulate cytoplasmic DDIT3 under
tunicamycin and etoposide induced stress conditions. Many studies
reporting nuclear localization of DDIT3 are made with cells
transfected or transduced with DDIT3 expression plasmids or
virus vectors. Transfection of fibroblasts and GOT3 cells with a
DDIT3-EGFP expression vector also showed nuclear expression
of the recombinant protein, indicating that these cells are capable
of nuclear DDIT3 localization (data not shown). With these results
we hypothesized that transfection induced stress could result in a
nuclear DDIT3 expression. However, transient transfections of
GOT3 cells with a GFP expression plasmid caused no change in
the localization of endogenous DDIT3. Inspection of western blot
results showed no detectable size difference between cytoplasmic
and nuclear DDIT3, eliminating major protein modifications such
as ubiquitinylation or sumoylation as a mechanism for the selective
localization. Nuclear localization of DDIT3 in mouse fibroblasts
has been reported to depend on dimerization of the short isoform,
LIP, of CEBPB, which also accumulates under stress [27,28].
CEBPB transcripts and the long (LAP) isoform of the protein are
constitutively expressed in the normal human fibroblasts, the
GOT3 and HT1080 cell lines used in this study [38,44] (Figure
S1). However, the LIP isoform was not detected, which may
explain why these cells express DDIT3 in the cytoplasm. We
conclude that ER stress and genotoxic stress caused cytoplasmic
accumulation of DDIT3 in the human cell types analyzed in this
study.
The observation that DDIT3 can be expressed both in the
cytoplasm and the nuclei has to be accounted for when biological
functions of this protein is studied. We studied the effects of
cytoplasmic DDIT3 and nuclear DDIT3 by analysis of two
transfected clones stably expressing recombinant DDIT3 protein
fused to the ligand binding parts of a mutated mouse estrogen
receptor and EGFP. The forced expression of DDIT3 differs from
the normal expression pattern of DDIT3, which is restricted to
stressed cells and during differentiation of some cell types. Stress
responses activates, however, several signaling pathways and
transcription factors that act in parallel with partly overlapping
functions, making it difficult to identify direct targets of DDIT3.
For example, studies of tunicamycin stressed ddit32/2 and wild
type mouse fibroblasts, identified target genes that most likely were
activated by DDIT3 in concert with other stress induced factors
[45,46,47].
Our applied experimental system allowed us to study the
cytoplasmic and nuclear effects of DDIT3 in a controlled manner.
The recombinant DDIT3 was under standard conditions retained
in the cytoplasmic compartment and 94 genes were down- or
upregulated three times or more compared to two morEGFP
Figure 4. DDIT3 induced cell cycle arrest. Flow cytometry analysis of DDIT3morEGFP expressing HT1080 cells cultured with and without
tamoxifen for 12 hours. Cells with nuclear DDIT3 were accumulated in G1-phase and depleted from the S- and G2-phases. Numbers of diploid cells in
G1-, G2- and M-phase are shown in black and S-phase cells are shown as striped. Aneuploid cells are shown in the white overlaying histogram.
doi:10.1371/journal.pone.0033208.g004
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control clones. Genes regulated by cytoplasmic DDIT3 were
obviously not direct targets. We speculate that cytoplasmic DDIT3
could bind and sequester other BZIP transcription factors and
prevent their nuclear localization. The role as a dominant negative
factor is further supported by the fact that most regulated genes
were suppressed, not induced (Figure 3 and Table S2). In addition
to CEBPB, the cells analyzed in this study constitutively express
ATF4 and low levels of ATF3 (Figure S1), thus making
dimerization possible with these known partners of DDIT3
[38,44,48,49]. Furthermore, the BZIP dimerization domain of
DDIT3 may bind several more BZIP containing factors and
thereby block/modify their activities [50]. The intrinsically
disordered DDIT3 domain may also mediate binding and
interactions with proteins other than leucine zippers [24].
Cytoplasmic DDIT3 may thus act through interactions both with
BZIP and other proteins.
Of the 94 genes, which were regulated 3-fold or more by
cytoplasmic DDIT3, only 3 (HSP1A, TPO and ATF3) were further
regulated by nuclear DDIT3. Interestingly, these three target
genes were regulated in opposite direction upon nuclear DDIT3
translocation, thus eliminating the effects of cytoplasmic DDIT3.
ATF3 may form heterodimers with DDIT3 [48] and both ATF3
and DDIT3 are upregulated by stress-activated ATF4, which is
another DDIT3 interacting BZIP transcription factor upstream in
ER stress signaling [49,51,52]. In vivo and in vitro studies have
shown that DDIT3 and ATF3 suppress each other’s expression at
the transcriptional level, leading to either DDIT3 or ATF3
expression in stressed cells and tissues. Our results, showing that
cytoplasmic DDIT3 induce and nuclear DDIT3 suppress ATF3
transcription, agrees with this model and add yet another level of
regulation that depends on the cellular localization of DDIT3.
In addition to the 94 genes regulated by cytoplasmic DDIT3, 84
more genes were regulated 2-fold or more by nuclear translocation of
DDIT3. Moreover, these genes were in the same functional
categories as the first 94 genes regulated by cytoplasmic DDIT3.
This shows that nuclear translocation steps up and modulates
functions already affected by cytoplasmic DDIT3. Decreasing the
threshold for cytoplasmic regulated genes to a 2-fold cutoff increased
the number of targets genes to 371, but only 8 of these genes were
identified as target genes for nuclear DDIT3. We hypothesize that a
DDIT3 leakage from the cytoplasm to the nucleus would result in
common target genes, but with a difference in regulation magnitude.
However, our data revealed very few overlapping genes, indicating
unique properties of cytoplasmic and nuclear localized DDIT3.
Ontogeny analysis of HT1080 cells with cytoplasmic DDIT3
showed that the category cellular movement was significantly affected.
DDIT3 regulation of several migration/movement-associated
genes may provide mechanistic explanations for the impaired
migration. For example, DSTN, which encodes an actin depoly-
merizing protein was downregulated in DDIT3 expressing cells.
We have previously shown that DDIT3 binds cyclin dependent
kinase 2 (CDK2) and that CDK2 also binds cytoskeletal proteins
such as myosin 9, myosin 10 and plectin in DDIT3 expressing cells
[53]. The CDK2 inhibitor CDKN1A/P21/waf1 is also downreg-
ulated by DDIT3 thus probably increasing presence of active
CDK2 [54]. These DDIT3 mediated protein interactions can
explain the decreased migration capacity.
Our results and ontogeny analysis suggest that nuclear DDIT3
controls cell growth. Forced expression of DDIT3 was reported to
induce a G1 cell cycle arrest [11] and our experimental system
recapitulated this effect when the protein was translocated to the
nuclei (Figure 4). Several of the regulated genes reported here may
execute the growth arrest but further investigations are needed to
dissect the mechanism (Table S2).
Previous studies report DDIT3 induced apoptosis in some cell
types [8]. In our experimental system no apoptosis was triggered.
This could be explained by that no stress inducing agents were
used and stress induced factors others than DDIT3 was not
expressed. Several apoptosis controlling genes were, however,
regulated and this depended on the cellular localization of DDIT3.
Upon nuclear localization the apoptosis protective genes PAX2,
PHLDA1, SGK1, SPRY2, and SYVN1 were all downregulated,
supporting a DDIT3 induction of apoptosis functions. This effect
was balanced by the simultaneous downregulation of the pro-
apoptotic genes KLF6, PLK2, RND3 and TXNIP.
The most upregulated gene induced by nuclear DDIT3 was
EGR1 that encodes a zinc finger type transcription factor involved
in a variety of biological responses and effects [55,56,57]. EGR1
forms a DNA binding complex with C/EBPB, which is an
important dimerization partner of DDIT3 [18]. Thus, DDIT3
may act both as an inducer of EGR1 and as a transcriptional
cofactor for regulation of C/EBPB-EGR1 target genes. EGR1 was
also pointed out as an important node in our network analysis
(Figure S5).
Screening for recurrent DDIT3 binding sites in the promoter
regions of regulated genes showed no common binding motif.
DDIT3 cannot form homodimers, but heterodimers with several
alternative transcription factors. The heterodimers probably bind
to different motifs and this may explain the lack of a common
DDIT3 motif in the response genes.
In summary, we show that DDIT3 may be expressed both as a
cytoplasmic and nuclear protein. Further, we show that cells
expressing cytoplasmic and nuclear DDIT3 have distinct gene
expression profiles, but that the target genes belong to the same
functional categories. Ninety-four genes were regulated by
cytoplasmic DDIT3 and 84 additional genes were regulated when
DDIT3 translocated to the nuclei. Most target genes were
downregulated supporting a dominant negative function of
DDIT3 in transcriptional regulation. Detailed characterization
of DDIT3 functions may help understanding its roles in cancer
and in diseases involving cell/tissue stress.
Supporting Information
Figure S1 Protein data for GOT3, F470 and HT1080
cells. (A) Etoposide induction of cytoplasmic DDIT3 in human
fibroblasts and GOT3 cells. Immunoblot analysis of DDIT3 in
nuclear (Nu) and cytoplasmic (Cy) extracts of human liposarcoma
cell line GOT3 and normal human fibroblasts F470 following
8 hours of etoposide (30 mM, Etopos) treatment. Cytoplasmic
accumulation of DDIT3 is seen in both cell lines compared to
untreated cells (Control). GAPDH and Lamin A are cytoplasmic
and nuclear markers, respectively. (B) Immunoblot analysis of
EGR1, ATF3 and ATF4 in HT1080 cells expressing DDIT3-
mor-EGFP or mor-EGFP. Addition of tamoxifen to cell cultures
(8 h and 12 h) caused an up-regulation of EGR1 in cells ex-
pressing DDIT3-mor-EGFP but not in mor-EGFP control cells.
The expression level of ATF3 was increased in cells expressing
cytoplasmic DDIT3-mor-EGFP (0 h) as compared to control
cells. Nuclear translocation of DDIT3-mor-EGFP (8 h and
12 h) caused a subsequent reduction in ATF3 levels compared
to cells with cytoplasmic DDIT3-mor-EGFP. ATF4 was detected
in all samples and showed no change in expression levels.
GAPDH and Lamin-A were used as loading controls for EGR1
and ATF3/ATF4 respectively. (C) Immunoblot analysis of
CEBPB expression in HT1080, GOT3 and cultured human
fibroblast (passage 9).
(TIF)
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Figure S2 Map of the recombinant DDIT3morEGFP
protein. The protein consist of the full length DDIT3 protein
juxtaposed to a mutated tamoxifen specific ligand binding part of the
mouse estrogen receptor (mor) and EGFP. The mor part mediates
cytoplasmic retention that is released upon addition of tamoxifen.
(TIF)
Figure S3 Overview of design and analysis ofmicroarray
experiments. Genes regulated by cytoplasmic DDIT3 were
extracted by making the comparison indicated with (1), comparing
the expression between the morEGFP and DDIT3morEGFP cell
lines before addition of tamoxifen. Genes regulated by nuclear
DDIT3 were extracted with the comparisons indicated by (2) and (3)
within the DDIT3morEGFP cell line, for 2 and 8 hours after
tamoxifen addition, respectively. Genes regulated in the morEGFP
cell line were removed before analysis of nuclear DDIT3 regulation.
Each square corresponds to a microarray experiment replicate.
(TIF)
Figure S4 Overlap of genes between functional catego-
ries. (a) Cytoplasmic DDIT3 induced genes.(b) Nuclear DDIT3
induced genes after 2 hours of tamoxifen addition. (c) Nuclear
DDIT3 induced genes after 8 hours of tamoxifen addition. Four
functional categories of genes are shown in (a) and the number of
genes that belongs to different categories is shown with overlapping
boxes. For example, one gene belongs to both Cell death and
Cellular movement, while four genes belong to Cell death, Cellular
development and Cellular Growth and Proliferation.
(TIFF)
Figure S5 Interaction networks formed by the genes
regulated by DDIT3. Red hues correspond to upregulation,
while green hues correspond to downregulation (no coloring
means no differential expression). Vertical diamonds, horizontal
diamonds, vertical ovals, and horizontal ovals represent enzymes,
peptidases, transmembrane receptors, and transcription factors,
respectively. Squares, rectangles, up-pointing triangles, and down-
pointing triangles denote cytokines, G-protein coupled receptors,
phosphatases, and kinases, in turn. Double circles, trapezoids, and
single circles symbolize complexes, transporters, and finally, gene
products with other functions. A dashed line corresponds to an
indirect relationship, while a solid line represents a direct
relationship. A. Interaction networks formed by genes regulated
by cytoplasmic DDIT3. B. Interaction networks formed by genes
regulated by nuclear DDIT3 after 2 hours of tamoxifen treatment.
EGR1 is indicated as a possible network hub (node connecting
several paths in the network). C. Interaction networks formed by
genes regulated by nuclear DDIT3 after 8 hours of tamoxifen
treatment. EGR1 is indicated as a possible network hub.
(TIF)
Figure S6 Comparison of regulated genes. Expression
within the morEGFP cell line, within the DDIT3morEGFP cell
line, and between both cell lines for genes regulated by cytoplasmic
DDIT3. Please note that genes showing differential expression in
the morEGFP cell line were excluded in the analysis of nuclear
DDIT3 regulation.
(TIF)
Figure S7 No general DDIT3 effects on cAMP regulated
genes. Log2 fold-changes for 6 genes following treatment with the
cAMP inducing agent forskolin in cells expressing EGFP or
nuclear DDIT3- EGFP. The gene expression ration between
forskolin treated (18 mM) and control cultured cells are shown.
The experiment was performed with 3 biological replicates, and
differences in induction between the two cell types were assessed
with a two-sample t-test (* P-value,0.05). Error bars indicate
standard error of the mean values.
(TIF)
Material and Methods S1 Migration assay modeling.
(PDF)
Material and Methods S2 Permutation test for promoter
analysis.
(PDF)
Movie S1 HT1080cell expressing DDIT3morEGFP re-
combinant proteins were treated with tamoxifen and the
effects were studied photographing every 20 seconds for
one hour.
(MOV)
Table S1 Sequence of primers used for QPCR analysis.
(XLS)
Table S2 Genes regulated by DDIT3.
(DOC)
Table S3 QPCR validation of microarray results.
(XLS)
Table S4 Functional categories regulated by DDIT3.
(XLS)
Table S5 Promoter analysis of DDIT3 regulated genes.
(XLS)
Author Contributions
Conceived and designed the experiments: PA˚ AJ AS CA CT ON.
Performed the experiments: CA CT LS AS PG AD MKA LR. Analyzed
the data: AJ ON PA˚ AS. Contributed reagents/materials/analysis tools:
PA˚ AS AJ. Wrote the paper: PA˚ AS AJ.
References
1. Liu T, Laurell C, Selivanova G, Lundeberg J, Nilsson P, et al. (2007) Hypoxia
induces p53-dependent transactivation and Fas/CD95-dependent apoptosis.
Cell Death Differ 14: 411–421.
2. Tang JR, Nakamura M, Okura T, Takata Y, Watanabe S, et al. (2002)
Mechanism of oxidative stress-induced GADD153 gene expression in vascular
smooth muscle cells. Biochem Biophys Res Commun 290: 1255–1259.
3. Ma Y, Brewer JW, Diehl JA, Hendershot LM (2002) Two distinct stress signaling
pathways converge upon the CHOP promoter during the mammalian unfolded
protein response. J Mol Biol 318: 1351–1365.
4. Jousse C, Bruhat A, Harding HP, Ferrara M, Ron D, et al. (1999) Amino acid
limitation regulates CHOP expression through a specific pathway independent
of the unfolded protein response. FEBS Lett 448: 211–216.
5. Jackman J, Alamo I, Jr., Fornace AJ, Jr. (1994) Genotoxic stress confers
preferential and coordinate messenger RNA stability on the five gadd genes.
Cancer Res 54: 5656–5662 Issn: 0008–5472.
6. Gately DP, Jones JA, Christen R, Barton RM, Los G, et al. (1994) Induction of
the growth arrest and DNA damage-inducible gene GADD153 by cisplatin in
vitro and in vivo. Br J Cancer 70: 1102–1106.
7. Luethy JD, Holbrook NJ (1992) Activation of the gadd153 promoter by
genotoxic agents: a rapid and specific response to DNA damage. Cancer Res 52:
5–10 Issn 0008–5472.
8. Oyadomari S, Mori M (2004) Roles of CHOP/GADD153 in endoplasmic
reticulum stress. Cell Death Differ 11: 381–389.
9. Ishikawa F, Akimoto T, Yamamoto H, Araki Y, Yoshie T, et al. (2009) Gene
expression profiling identifies a role for CHOP during inhibition of the
mitochondrial respiratory chain. J Biochem 146: 123–132.
10. Maytin EV, Ubeda M, Lin JC, Habener JF (2001) Stress-inducible transcrip-
tion factor CHOP/gadd153 induces apoptosis in mammalian cells via p38
kinase-dependent and -independent mechanisms. Exp Cell Res 267: 193–
204.
11. Barone MV, Crozat A, Tabaee A, Philipson L, Ron D (1994) CHOP
(GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on
the induction of G1/S arrest. Genes Dev 8: 453–464.
12. Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, et al. (1998)
CHOP is implicated in programmed cell death in response to impaired function
of the endoplasmic reticulum. Genes Dev 12: 982–995.
Effects of Nuclear and Cytoplasmic DDIT3
PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e33208
13. Diakogiannaki E, Dhayal S, Childs CE, Calder PC, Welters HJ, et al. (2007)
Mechanisms involved in the cytotoxic and cytoprotective actions of saturated
versus monounsaturated long-chain fatty acids in pancreatic beta-cells.
J Endocrinol 194: 283–291.
14. Araki E, Oyadomari S, Mori M (2003) Impact of endoplasmic reticulum stress
pathway on pancreatic beta-cells and diabetes mellitus. Exp Biol Med
(Maywood) 228: 1213–1217.
15. Engstrom K, Willen H, Kabjorn-Gustafsson C, Andersson C, Olsson M, et al.
(2006) The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and
the normal DDIT3 induce a liposarcoma phenotype in transfected human
fibrosarcoma cells. Am J Pathol 168: 1642–1653.
16. Thorp E, Li G, Seimon TA, Kuriakose G, Ron D, et al. (2009) Reduced
apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe2/2
and Ldlr2/2 mice lacking CHOP. Cell Metab 9: 474–481.
17. Batchvarova N, Wang XZ, Ron D (1995) Inhibition of adipogenesis by the
stress-induced protein CHOP (Gadd153). Embo J 14: 4654–4661.
18. Ron D, Habener JF (1992) CHOP, a novel developmentally regulated nuclear
protein that dimerizes with transcription factors C/EBP and LAP and functions
as a dominant-negative inhibitor of gene transcription. Genes Dev 6: 439–453.
19. Shirakawa K, Maeda S, Gotoh T, Hayashi M, Shinomiya K, et al. (2006)
CCAAT/enhancer-binding protein homologous protein (CHOP) regulates
osteoblast differentiation. Mol Cell Biol 26: 6105–6116.
20. Crozat A, A˚man P, Mandahl N, Ron D (1993) Fusion of CHOP to a novel
RNA-binding protein in human myxoid liposarcoma. Nature 363: 640–644.
21. Persson F, Olofsson A, Sjogren H, Chebbo N, Nilsson B, et al. (2008)
Characterization of the 12q amplicons by high-resolution, oligonucleotide array
CGH and expression analyses of a novel liposarcoma cell line. Cancer Lett 260:
37–47.
22. Wedel A, Ziegler-Heitbrock HWL (1995) The C/EBP family of transcription
factors. Immunobiol 193: 171–185.
23. Ubeda M, Wang X-Z, Zinszer H, Wu I, Habener J, et al. (1996) Stress-induced
binding of the transcription factor CHOP to a novel DNA control element. Mol
Cell Biol 16: 1479–1489.
24. Singh VK, Pacheco I, Uversky VN, Smith SP, MacLeod RJ, et al. (2008)
Intrinsically disordered human C/EBP homologous protein regulates biological
activity of colon cancer cells during calcium stress. J Mol Biol 380: 313–326.
25. Cui K, Coutts M, Stahl J, Sytkowski AJ (2000) Novel interaction between the
transcription factor CHOP (GADD153) and the ribosomal protein FTE/S3a
modulates erythropoiesis. J Biol Chem 275: 7591–7596.
26. Lorz C, Justo P, Sanz A, Subira D, Egido J, et al. (2004) Paracetamol-induced
renal tubular injury: a role for ER stress. J Am Soc Nephrol 15: 380–389.
27. Chiribau CB, Gaccioli F, Huang CC, Yuan CL, Hatzoglou M (2010) Molecular
symbiosis of CHOP and C/EBP beta isoform LIP contributes to endoplasmic
reticulum stress-induced apoptosis. Molecular and cellular biology 30:
3722–3731.
28. Li Y, Bevilacqua E, Chiribau CB, Majumder M, Wang C, et al. (2008)
Differential control of the CCAAT/enhancer-binding protein beta (C/EBPbeta)
products liver-enriched transcriptional activating protein (LAP) and liver-
enriched transcriptional inhibitory protein (LIP) and the regulation of gene
expression during the response to endoplasmic reticulum stress. The Journal of
biological chemistry 283: 22443–22456.
29. Thelin-Ja¨rnum S, Go¨ransson M, Burguete AS, Olofsson A, A˚man P (2002) The
myxoid liposarcoma specific TLS-CHOP fusion protein localizes to nuclear
structures distinct from PML nuclear bodies. Int J Cancer 97: 446–450.
30. Chen Z, Ruffner DE (1998) Amplification of closed circular DNA in vitro.
Nucleic Acids Res 26: 1126–1127.
31. Littlewood TD, Hancock DC, Danielian PS, Parker MG, Evan GI (1995) A
modified oestrogen receptor ligand-binding domain as an improved switch for
the regulation of heterologous proteins. Nucleic Acids Res 23: 1686–1690.
32. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004)
Bioconductor: open software development for computational biology and
bioinformatics. Genome biology 5: R80.
33. Agresti A (2002) Categorical data analysis. New York; Chichester: Wiley-Interscience.
xv, 710 p.
34. Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, et al. (2003)
MATCH: A tool for searching transcription factor binding sites in DNA
sequences. Nucleic Acids Res 31: 3576–3579.
35. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, et al. (2006)
TRANSFAC and its module TRANSCompel: transcriptional gene regulation in
eukaryotes. Nucleic Acids Res 34: D108–110.
36. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002)
Accurate normalization of real-time quantitative RT-PCR data by geometric
averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
37. Andersson MK, Sta˚hlberg A, Arvidsson Y, Olofsson A, Semb H, et al. (2008)
The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-
specific expression patterns and involvement in cell spreading and stress
response. BMC Cell Biol 9: 37.
38. Go¨ransson M, Elias E, Sta˚hlberg A, Olofsson A, Andersson C, et al. (2005)
Myxoid liposarcoma FUS-DDIT3 fusion oncogene induces C/EBP beta-
mediated interleukin 6 expression. Int J Cancer 115: 556–560.
39. Gachon F, Gaudray G, Thebault S, Basbous J, Koffi JA, et al. (2001) The cAMP
response element binding protein-2 (CREB-2) can interact with the C/EBP-
homologous protein (CHOP). FEBS Lett 502: 57–62.
40. Jousse C, Bruhat A, Carraro V, Urano F, Ferrara M, et al. (2001) Inhibition of
CHOP translation by a peptide encoded by an open reading frame localized in
the chop 59UTR. Nucleic Acids Res 29: 4341–4351.
41. Pereira RC, Stadmeyer L, Marciniak SJ, Ron D, Canalis E (2006) C/EBP
homologous protein is necessary for normal osteoblastic function. Journal of
cellular biochemistry 97: 633–640.
42. Gotoh T, Oyadomari S, Mori K, Mori M (2002) Nitric oxide-induced apoptosis
in RAW 264.7 macrophages is mediated by endoplasmic reticulum stress
pathway involving ATF6 and CHOP. The Journal of biological chemistry 277:
12343–12350.
43. Oyadomari S, Koizumi A, Takeda K, Gotoh T, Akira S, et al. (2002) Targeted
disruption of the Chop gene delays endoplasmic reticulum stress-mediated
diabetes. The Journal of clinical investigation 109: 525–532.
44. Go¨ransson M, Andersson MK, Forni C, Sta˚hlberg A, Andersson C, et al. (2009)
The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-
kappaB target genes by interaction with NFKBIZ. Oncogene 28: 270–278.
45. Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, et al. (2004) CHOP
induces death by promoting protein synthesis and oxidation in the stressed
endoplasmic reticulum. Genes Dev 18: 3066–3077.
46. Sok J, Wang XZ, Batchvarova N, Kuroda M, Harding H, et al. (1999) CHOP-
Dependent stress-inducible expression of a novel form of carbonic anhydrase VI.
Mol Cell Biol 19: 495–504.
47. Wang XZ, Kuroda M, Sok J, Batchvarova N, Kimmel R, et al. (1998)
Identification of novel stress-induced genes downstream of chop. Embo J 17:
3619–3630.
48. Chen BP, Wolfgang CD, Hai T (1996) Analysis of ATF3, a transcription factor
induced by physiological stresses and modulated by gadd153/Chop10. Mol Cell
Biol 16: 1157–1168.
49. Su N, Kilberg MS (2008) C/EBP homology protein (CHOP) interacts with
activating transcription factor 4 (ATF4) and negatively regulates the stress-
dependent induction of the asparagine synthetase gene. J Biol Chem 12;283:
35106–35117.
50. Newman JR, Keating AE (2003) Comprehensive identification of human bZIP
interactions with coiled-coil arrays. Science 300: 2097–2101.
51. Fawcett TW, Martindale JL, Guyton KZ, Hai T, Holbrook NJ (1999)
Complexes containing activating transcription factor (ATF)/cAMP-responsive-
element-binding protein (CREB) interact with the CCAAT/enhancer-binding
protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the
stress response. The Biochemical journal 339(Pt 1): 135–141.
52. Pan YX, Chen H, Thiaville MM, Kilberg MS (2007) Activation of the ATF3
gene through a co-ordinated amino acid-sensing response programme that
controls transcriptional regulation of responsive genes following amino acid
limitation. The Biochemical journal 401: 299–307.
53. Bento C, Andersson MK, A˚man P (2009) DDIT3/CHOP and the sarcoma
fusion oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2.
BMC Cell Biol 10: 89.
54. Mihailidou C, Papazian I, Papavassiliou AG, Kiaris H (2010) CHOP-dependent
regulation of p21/waf1 during ER stress. Cellular physiology and biochemistry :
international journal of experimental cellular physiology, biochemistry, and
pharmacology 25: 761–766.
55. Adamson ED, Mercola D (2002) Egr1 transcription factor: multiple roles in
prostate tumor cell growth and survival. Tumour Biol 23: 93–102.
56. Krones-Herzig A, Mittal S, Yule K, Liang H, English C, et al. (2005) Early
growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation
of p53. Cancer Res 65: 5133–5143.
57. Yu J, Baron V, Mercola D, Mustelin T, Adamson ED (2007) A network of p73,
p53 and Egr1 is required for efficient apoptosis in tumor cells. Cell Death Differ
14: 436–446.
Effects of Nuclear and Cytoplasmic DDIT3
PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e33208
